Is Mounjaro a placebo, or does the evidence stack up?

Step 1: understanding what a placebo-controlled trial actually proves

A placebo-controlled trial gives one group of participants an inactive substance (identical in appearance to the real thing) and another group the actual medicine. Neither group knows which they have received. If both groups show the same result, the medicine has no effect beyond expectation. If the medicine group shows a substantially different result, the effect is real.

SURMOUNT-1 did exactly this. Randomised, double-blind, 72 weeks, 2,539 adults with obesity and no diabetes. The placebo group lost a modest amount of weight, consistent with the lifestyle support given to everyone in the trial. The tirzepatide 15mg group lost around 20–21% of their starting body weight on average. That gap cannot be explained by belief or expectation. You can read the full trial paper on the SURMOUNT-1 publication in the New England Journal of Medicine.

NICE reviewed that evidence independently and recommended tirzepatide for eligible adults in its appraisal TA1026, published in December 2024. NICE's processes are not lenient; a medicine with placebo-equivalent effects would not pass.

Step 2: the mechanism is observable, not theoretical

Scepticism about weight-loss medicines sometimes rests on the idea that they work through willpower by proxy, that patients eat less simply because they believe the medicine is doing something. Tirzepatide's effects are measurable at the molecular level. It binds to GIP and GLP-1 receptors in the gut, pancreas and brain. Gastric emptying slows. Appetite-regulating hormones shift. Blood-glucose response changes. These are not experiences that a participant can fake or imagine into existence, and researchers can observe many of them independently of how much weight a person loses.

The side-effect profile is itself evidence of biological activity. Nausea, constipation, reduced appetite and indigestion are well-documented in both trial populations and real-world users. They occur because the medicine is acting on the gastrointestinal system. Placebo participants in SURMOUNT-1 did not report these effects at the same rate. If Mounjaro were inert, it would not produce this pattern.

People wondering about the science behind tirzepatide more broadly can find a plain-language overview on the tirzepatide information page, and a detailed look at the medicine itself on our Mounjaro page.

Step 3: why results vary, and what that doesn't mean

Even with strong trial evidence, individual results differ. Someone on 5mg who loses 8% of their body weight after six months may feel the medicine isn't working, especially if they have seen reports of 20% losses online. A few things are worth knowing here.

First, the 20–21% figure is an average across all participants at the highest dose, at week 72. Many people started at 2.5mg, a tolerability dose that exists to help the body adjust rather than to produce rapid loss. Full therapeutic effect typically builds across many months as doses are titrated upward. Second, a medicine cannot override a sustained caloric surplus: Mounjaro reduces appetite, but dietary habits still matter alongside it. Third, some people respond more than others based on biology, dose, duration and lifestyle, which is true of almost every medicine, not a sign of placebo. A quick check you can do right now: look at the leaflet inside your pen and confirm the dose you are on. If you are still at 2.5mg or 5mg months in, that context matters for how you interpret your results.

For people thinking about where to get started, reading about where to get Mounjaro through a regulated route is a sensible first step, and our guide on where is the best place to get Mounjaro walks through the key questions to ask before committing to a provider.

Placebo concerns, fake pens and why the source matters

There is, however, a version of the placebo question that deserves a direct answer: some products sold online without a valid prescription may genuinely be counterfeit or contain little to no active ingredient. The MHRA has confirmed seizures of fake weight-loss pens in the UK, including at least one illicit manufacturing site producing counterfeit tirzepatide. If someone bought a pen from an unverified social-media seller and noticed no effect, it is entirely possible the product was not genuine tirzepatide at all.

This is a different problem from asking whether the licensed medicine works. It is a supply-chain problem, and the answer to it is straightforward: Mounjaro should only be obtained through a pharmacy registered with the GPhC, following a proper clinical assessment. Our page covering the best places to get Mounjaro explains what to look for in a provider and how to confirm you are dealing with a legitimate, regulated service. You can also verify any online pharmacy at the GPhC register. Report any suspect sellers via the MHRA's Yellow Card scheme.

At nume, medicines are sourced through the licensed UK supply chain via Eli Lilly's authorised network. Every order follows a clinical review by a GPhC-registered Independent Prescriber, a real clinician reads your consultation, not software. Our about us page explains how the service is structured, and you can read more about our clinical team at the prescriber profile page. For questions about the process, the FAQs page covers the most common ones.

If you are thinking about treatment, the place to start is a free consultation, there is no commitment, and one of our prescribers will assess whether Mounjaro is clinically suitable for you. If you are also unsure about injection technique, our guide on the best place to jab Mounjaro covers the recommended sites and how to rotate them safely. Details of all available treatments are on the weight-loss treatments page.